Kejin Wu

904 total citations
27 papers, 499 citations indexed

About

Kejin Wu is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Kejin Wu has authored 27 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cancer Research, 12 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Kejin Wu's work include Breast Cancer Treatment Studies (13 papers), HER2/EGFR in Cancer Research (5 papers) and Breast Lesions and Carcinomas (5 papers). Kejin Wu is often cited by papers focused on Breast Cancer Treatment Studies (13 papers), HER2/EGFR in Cancer Research (5 papers) and Breast Lesions and Carcinomas (5 papers). Kejin Wu collaborates with scholars based in China, United States and Croatia. Kejin Wu's co-authors include Mingdi Zhang, Hongliang Chen, Peng Zhang, Maoli Wang, Fang Bai, Yi‐Peng Fu, Bin Li, Qianru Huang, Dan Li and Yunshu Lu and has published in prestigious journals such as PLoS ONE, Cancer and Cancer Research.

In The Last Decade

Kejin Wu

26 papers receiving 493 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kejin Wu China 14 228 204 199 91 71 27 499
Hanan Ahmed Wahba Egypt 8 140 0.6× 226 1.1× 238 1.2× 94 1.0× 42 0.6× 24 529
Zhenzhen Xu China 13 181 0.8× 268 1.3× 215 1.1× 72 0.8× 40 0.6× 28 575
Hend Ahmed El-Hadaad Egypt 9 140 0.6× 241 1.2× 243 1.2× 105 1.2× 36 0.5× 25 552
Elisabeth Werner Rönnerman Sweden 11 160 0.7× 200 1.0× 161 0.8× 73 0.8× 44 0.6× 23 472
Xi Gu China 11 158 0.7× 186 0.9× 146 0.7× 60 0.7× 39 0.5× 21 407
Venkat R. Katkoori United States 15 199 0.9× 342 1.7× 243 1.2× 56 0.6× 122 1.7× 34 621
Elena Vagia United States 9 153 0.7× 226 1.1× 256 1.3× 125 1.4× 35 0.5× 25 493
Jianhuang Li China 14 219 1.0× 422 2.1× 166 0.8× 82 0.9× 38 0.5× 24 640
Carla Azzurra Amoreo Italy 15 148 0.6× 249 1.2× 193 1.0× 75 0.8× 61 0.9× 25 492
Caroline Coghlin United Kingdom 6 134 0.6× 205 1.0× 185 0.9× 106 1.2× 34 0.5× 10 447

Countries citing papers authored by Kejin Wu

Since Specialization
Citations

This map shows the geographic impact of Kejin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kejin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kejin Wu more than expected).

Fields of papers citing papers by Kejin Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kejin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kejin Wu. The network helps show where Kejin Wu may publish in the future.

Co-authorship network of co-authors of Kejin Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Kejin Wu. A scholar is included among the top collaborators of Kejin Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kejin Wu. Kejin Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Zhiyuan, Qianru Huang, Yiran Qiu, et al.. (2024). LILRB2 promotes immune escape in breast cancer cells via enhanced HLA-A degradation. Cellular Oncology. 47(5). 1679–1696. 6 indexed citations
2.
Yuan, Jingjing, Meilin Zhang, Maoli Wang, et al.. (2024). Neoadjuvant radiochemotherapy is safe and feasible for breast conserving surgery or immediate reconstruction. Scientific Reports. 14(1). 9208–9208. 1 indexed citations
3.
Gao, Anran, et al.. (2023). Reliable breast cancer miRNAs detection with enhanced silicon nanowire biosensor by PNA probe and optical calibration. Sensors and Actuators B Chemical. 401. 135011–135011. 10 indexed citations
5.
Yu, Ke‐Da, Xiyu Liu, Li Chen, et al.. (2021). Anthracycline-free or short-term regimen as adjuvant chemotherapy for operable breast cancer: A phase III randomized non-inferiority trial. The Lancet Regional Health - Western Pacific. 11. 100158–100158. 9 indexed citations
6.
Zhang, Mingdi, Kejin Wu, Peng Zhang, et al.. (2021). HOTAIR Facilitates Endocrine Resistance in Breast Cancer Through ESR1/miR-130b-3p Axis: Comprehensive Analysis of mRNA-miRNA-lncRNA Network. International Journal of General Medicine. Volume 14. 4653–4663. 13 indexed citations
7.
Bai, Fang, Peng Zhang, Yi‐Peng Fu, et al.. (2020). Targeting ANXA1 abrogates Treg-mediated immune suppression in triple-negative breast cancer. Journal for ImmunoTherapy of Cancer. 8(1). e000169–e000169. 82 indexed citations
8.
Zhang, Mingdi, Kejin Wu, Peng Zhang, et al.. (2020). Breast-Conserving Surgery is Oncologically Safe for Well-Selected, Centrally Located Breast Cancer. Annals of Surgical Oncology. 28(1). 330–339. 8 indexed citations
9.
Chen, Hongliang, Fang Bai, Maoli Wang, et al.. (2019). The prognostic significance of co-existence ductal carcinoma in situ in invasive ductal breast cancer: a large population-based study and a matched case-control analysis. Annals of Translational Medicine. 7(18). 484–484. 19 indexed citations
11.
Chen, Hongliang, Mingdi Zhang, Maoli Wang, et al.. (2018). Immediate Breast Reconstruction in De Novo Metastatic Breast Cancer: An Analysis of 563 Cases Based on the SEER Database. Clinical Breast Cancer. 19(1). e135–e141. 8 indexed citations
14.
Jia, Yijun, Chuanying Wang, Mingjie Zhu, et al.. (2016). Increased chemosensitivity and radiosensitivity of human breast cancer cell lines treated with novel functionalized single-walled carbon nanotubes. Oncology Letters. 13(1). 206–214. 23 indexed citations
15.
Weng, Mingzhe, Mingdi Zhang, Yiyu Qin, et al.. (2014). Targeting gallbladder carcinoma: bone marrow-derived stem cells as therapeutic delivery vehicles of myxoma virus. Chinese Medical Journal. 127(12). 2350–2356. 10 indexed citations
16.
Wang, Yongkun, Chuanying Wang, Yijun Jia, et al.. (2014). Oxygen-Carbon Nanotubes as a Chemotherapy Sensitizer for Paclitaxel in Breast Cancer Treatment. PLoS ONE. 9(8). e104209–e104209. 15 indexed citations
17.
Liu, Tianyu, Zhujun Tan, Lin Jiang, et al.. (2013). Curcumin induces apoptosis in gallbladder carcinoma cell line GBC-SD cells. Cancer Cell International. 13(1). 64–64. 65 indexed citations
18.
Wu, Kejin, Shuo Huang, Mingjie Zhu, et al.. (2013). Expression of synuclein gamma indicates poor prognosis of triple-negative breast cancer. Medical Oncology. 30(3). 612–612. 14 indexed citations
20.
Chen, Jian, Shuo Huang, Kejin Wu, et al.. (2013). [The correlation of synuclein-γ and matrix metalloproteinase 9 in breast cancer].. PubMed. 51(7). 641–4. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026